These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33981608)

  • 1. Which Way to Choose for the Treatment of Metastatic Prostate Cancer: A Case Report and Literature Review.
    Yang X; Jiang D; Li Y; Zhang T; Xu D; Chen X; Pang J
    Front Oncol; 2021; 11():659442. PubMed ID: 33981608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
    Kosaka T; Hongo H; Oya M
    BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Detected by Choroidal Tumor and Complete Response to Hormonal Therapy: Case Report and Literature Review of 24 Patients With Choroidal Metastasis From Prostate Cancer.
    Matsuo T; Tanaka T; Nakamura A; Wada K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211026471. PubMed ID: 34159819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
    Murray SK; Breau RH; Guha AK; Gupta R
    Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment gains from the "sandwich method" of abiraterone acetate for men with metastatic prostate cancer: a case report and sharing of our experience.
    Wang H; Li X; Zhang P; Liu S; Xie Q; Zhao S
    Transl Androl Urol; 2020 Jun; 9(3):1448-1458. PubMed ID: 32676430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
    Iwamura H; Hatakeyama S; Tanaka Y; Tanaka T; Tokui N; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Ohyama C
    BMC Res Notes; 2014 Jan; 7():64. PubMed ID: 24476098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : a case report].
    Fujita M; Goto T; Uchida K; Saiki S; Arima R
    Hinyokika Kiyo; 2013 Mar; 59(3):183-8. PubMed ID: 23633635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental finding of metastatic prostatic adenocarcinoma of cerebellopontine angle presenting as acoustic neuroma: A case report and review of literature.
    Ma QF; Ou CY; Wang QH; Wang YN
    Int J Surg Case Rep; 2022 Sep; 98():107493. PubMed ID: 35969908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; Van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Eur Urol; 2011 Apr; 59(4):572-83. PubMed ID: 21315502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abiraterone acetate withdrawal syndrome: Speculations on the underlying mechanisms.
    Kato T; Komiya A; Yuasa J; Kaga K; Kaga M; Kojima S; Naya Y; Isaka S
    Oncol Lett; 2018 Feb; 15(2):2669-2672. PubMed ID: 29434990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
    Martínez-Piñeiro L; Schalken JA; Cabri P; Maisonobe P; de la Taille A;
    BJU Int; 2014 Oct; 114(4):608-16. PubMed ID: 24806330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarkable response to abiraterone acetate in castration-resistant prostate cancer patient with aggressive liver metastasis.
    Katsui M; Ohigashi T; Kosaka T; Bessho H; Arakawa T
    IJU Case Rep; 2019 Jan; 2(1):12-14. PubMed ID: 32743362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual presentation of metastatic prostate cancer in a 44-year-old man: A case report and review of the literature.
    Taheri H; Ebrahimi P; Nazari P; Kefayat A; Mahdavian A
    Clin Case Rep; 2024 Feb; 12(2):e8447. PubMed ID: 38292222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml.
    Persec Z; Persec J; Sović T; Romic Z; Bosnar Herak M; Hrgovic Z
    Onkologie; 2010; 33(3):110-2. PubMed ID: 20215802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
    James ND; Spears MR; Clarke NW; Dearnaley DP; De Bono JS; Gale J; Hetherington J; Hoskin PJ; Jones RJ; Laing R; Lester JF; McLaren D; Parker CC; Parmar MKB; Ritchie AWS; Russell JM; Strebel RT; Thalmann GN; Mason MD; Sydes MR
    Eur Urol; 2015 Jun; 67(6):1028-1038. PubMed ID: 25301760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.